Quantification of antineural antibodies in autoimmune neurological disorders

References

• Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr. Opin. Immunol.7(6), 812–818 (1995).
   PubMed Web of Science ®Google Scholar
• Merbl Y, Zucker-Toledano M, Quintana FJ, Cohen IR. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J. Clin. Invest.117(3), 712–718 (2007).
   PubMed Web of Science ®Google Scholar
• Pulendran B, van Driel R, Nossal GJ. Immunological tolerance in germinal centres. Immunol. Today18(1), 27–32 (1997).
   PubMedGoogle Scholar
• Oldstone MB. Molecular mimicry and autoimmune disease. Cell50(6), 819–820 (1987).
   PubMed Web of Science ®Google Scholar
• Sakaguchi N, Miyai K, Sakaguchi S. Ionizing radiation and autoimmunity. Induction of autoimmune disease in mice by high dose fractionated total lymphoid irradiation and its prevention by inoculating normal T cells. J. Immunol.152(5), 2586–2595 (1994).
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A. Drug-induced lupus erythematosus. Autoimmunity38(7), 507–518 (2005).
   PubMed Web of Science ®Google Scholar
• Posada de la Paz M, Philen RM, Borda AI. Toxic oil syndrome: the perspective after 20 years. Epidemiol. Rev.23(2), 231–247 (2001).
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, You S et al. Tryptophan catabolism generates autoimmune-preventive regulatory T cells. Transpl. Immunol.17(1), 58–60 (2006).
   PubMed Web of Science ®Google Scholar
• Sobel ES, Gianini J, Butfiloski EJ, Croker BP, Schiffenbauer J, Roberts SM. Acceleration of autoimmunity by organochlorine pesticides in (NZB × NZW)F1 mice. Environ. Health Perspect.113(3), 323–328 (2005).
   PubMed Web of Science ®Google Scholar
• Havarinasab S, Hultman P. Organic mercury compounds and autoimmunity. Autoimmun. Rev.4(5), 270–275 (2005).
   PubMed Web of Science ®Google Scholar
• Keusch GT. The history of nutrition: malnutrition, infection and immunity. J. Nutr.133(1), 336S–340S (2003).
   PubMed Web of Science ®Google Scholar
• Kagnoff MF. Celiac disease: pathogenesis of a model immunogenetic disease. J. Clin. Invest.117(1), 41–49 (2007).
   PubMed Web of Science ®Google Scholar
• Mori M, Yamada R, Kobayashi K, Kawaida R, Yamamoto K. Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J. Hum. Genet.50(5), 264–266 (2005).
   PubMed Web of Science ®Google Scholar
• Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves’ disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab.86(2), 930–934 (2001).
   PubMed Web of Science ®Google Scholar
• Winchester R. The genetics of autoimmune-mediated rheumatic diseases: clinical and biologic implications. Rheum. Dis. Clin. North Am.30(1), 213–227, viii (2004).
   PubMedGoogle Scholar
• Melanitou E. The autoimmune contrivance: genetics in the mouse model. Clin. Immunol.117(3), 195–206 (2005).
   PubMedGoogle Scholar
• Kono DH, Theofilopoulos AN. Genetics of systemic autoimmunity in mouse models of lupus. Int. Rev. Immunol.19(4–5), 367–387 (2000).
   PubMedGoogle Scholar
• Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell85(3), 299–302 (1996).
   PubMed Web of Science ®Google Scholar
• Meeker ND, Hickey WF, Korngold R et al. Multiple loci govern the bone marrow-derived immunoregulatory mechanism controlling dominant resistance to autoimmune orchitis. Proc. Natl Acad. Sci. USA92(12), 5684–5688 (1995).
   PubMedGoogle Scholar
• Wardell BB, Michael SD, Tung KS et al. Aod1, the immunoregulatory locus controlling abrogation of tolerance in neonatal thymectomy-induced autoimmune ovarian dysgenesis, maps to mouse chromosome 16. Proc. Natl Acad. Sci. USA92(11), 4758–4762 (1995).
   PubMed Web of Science ®Google Scholar
• Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens64(6), 631–649 (2004).
   PubMedGoogle Scholar
• Warrens AN, Lechler RI. HLA in Health and Disease. Academic Press, London, UK (2000).
   Google Scholar
• Pearce SH, Merriman TR. Genetic progress towards the molecular basis of autoimmunity. Trends Mol. Med.12(2), 90–98 (2006).
   PubMed Web of Science ®Google Scholar
• Carlton VE, Hu X, Chokkalingam AP et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am. J. Hum. Genet.77(4), 567–581 (2005).
   PubMed Web of Science ®Google Scholar
• Vaidya B, Imrie H, Perros P et al. The cytotoxic T lymphocyte antigen-4 is a major Graves’ disease locus. Hum. Mol. Genet.8(7), 1195–1199 (1999).
   PubMed Web of Science ®Google Scholar
• Donner H, Braun J, Seidl C et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto’s thyroiditis and Addison’s disease. J. Clin. Endocrinol. Metab.82(12), 4130–4132 (1997).
   PubMed Web of Science ®Google Scholar
• Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases – a general susceptibility gene to autoimmunity? Genes Immun.1(3), 170–184 (2000).
   PubMed Web of Science ®Google Scholar
• Ferreiros-Vidal I, Gomez-Reino JJ, Barros F et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum.50(8), 2590–2597 (2004).
   PubMed Web of Science ®Google Scholar
• Prokunina L, Padyukov L, Bennet A et al. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum.50(6), 1770–1773 (2004).
   PubMed Web of Science ®Google Scholar
• Sutherland A, Davies J, Owen CJ et al. Genomic polymorphism at the interferon-induced helicase (Ifih1) locus contributes to Graves’ disease susceptibility. J. Clin. Endocrinol. Metab.92(8), 3338–3341 (2007).
   PubMed Web of Science ®Google Scholar
• Newman B, Gu X, Wintle R et al. A risk haplotype in the solute carrier family 22A4/22A5 gene cluster influences phenotypic expression of Crohn’s disease. Gastroenterology128(2), 260–269 (2005).
   PubMed Web of Science ®Google Scholar
• Kochi Y, Yamada R, Suzuki A et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet.37(5), 478–485 (2005).
   PubMed Web of Science ®Google Scholar
• Pittock SJ, Yoshikawa H, Ahlskog JE et al. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clinic Proc.81(9), 1207–1214 (2006).
   PubMedGoogle Scholar
• Yacoub Wasef SZ. Gender differences in systemic lupus erythematosus. Gend. Med.1(1), 12–17 (2004).
   PubMedGoogle Scholar
• Delpy L, Douin-Echinard V, Garidou L, Bruand C, Saoudi A, Guery JC. Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. J. Immunol.175(8), 5050–5057 (2005).
   PubMed Web of Science ®Google Scholar
• Cutolo M, Capellino S, Sulli A et al. Estrogens and autoimmune diseases. Ann. NY Acad. Sci.1089, 538–547 (2006).
   PubMed Web of Science ®Google Scholar
• Mirone L, Barini A, Barini A. Androgen and prolactin (Prl) levels in systemic sclerosis (SSc): relationship to disease severity. Ann. NY Acad. Sci.1069, 257–262 (2006).
   PubMedGoogle Scholar
• Nilsson BO, Skogh T, Ernerudh J et al. Antinuclear antibodies in the oldest-old women and men. J. Autoimmun.27(4), 281–288 (2006).
   PubMed Web of Science ®Google Scholar
• Lang B, Dale RC, Vincent A. New autoantibody mediated disorders of the central nervous system. Curr. Opin. Neurol.16(3), 351–357 (2003).
   PubMed Web of Science ®Google Scholar
• Morgan BP, Gasque P. Expression of complement in the brain: role in health and disease. Immunol. Today17(10), 461–466 (1996).
   PubMedGoogle Scholar
• Terryberry JW, Thor G, Peter JB. Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. Neurobiol. Aging19(3), 205–216 (1998).
   PubMed Web of Science ®Google Scholar
• Vega F, Graus F, Chen QM, Poisson M, Schuller E, Delattre JY. Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation. Neurology44(11), 2145–2147 (1994).
   PubMed Web of Science ®Google Scholar
• Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat. Med.2(12), 1382–1385 (1996).
   PubMed Web of Science ®Google Scholar
• Su W, Madaio MP. Recent advances in the pathogenesis of lupus nephritis: autoantibodies and B cells. Semin. Nephrol.23(6), 564–568 (2003).
   PubMedGoogle Scholar
• Chand N, Mihas AA. Celiac disease: current concepts in diagnosis and treatment. J. Clin. Gastroenterol.40(1), 3–14 (2006).
   PubMedGoogle Scholar
• De Camilli P, Thomas A, Cofiell R et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-man syndrome with breast cancer. J. Exp. Med.178(6), 2219–2223 (1993).
   PubMed Web of Science ®Google Scholar
• Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med.3(7), 797–801 (1997).
   PubMed Web of Science ®Google Scholar
• Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J. Exp. Med.195(6), 747–757 (2002).
   PubMed Web of Science ®Google Scholar
• Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med.202(4), 473–477 (2005).
   PubMed Web of Science ®Google Scholar
• Drost G, Verrips A, Hooijkaas H, Zwarts M. Glutamic acid decarboxylase antibodies in Satoyoshi syndrome. Ann. Neurol.55(3), 450–451 (2004).
   PubMedGoogle Scholar
• Mitoma H, Song SY, Ishida K, Yamakuni T, Kobayashi T, Mizusawa H. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J. Neurol. Sci.175(1), 40–44 (2000).
   PubMed Web of Science ®Google Scholar
• Vianello M, Tavolato B, Giometto B. Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol. Sci.23(4), 145–151 (2002).
   PubMed Web of Science ®Google Scholar
• Gold R, Stangel M, Dalakas MC. Drug insight: the use of intravenous immunoglobulin in neurology – therapeutic considerations and practical issues. Nat. Clin. Pract.3(1), 36–44 (2007).
   Google Scholar
• Toyka KV, Drachman DB, Griffin DE et al. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N. Engl. J. Med.296(3), 125–131 (1977).
   PubMed Web of Science ®Google Scholar
• Sommer C, Weishaupt A, Brinkhoff J et al. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet365(9468), 1406–1411 (2005).
   PubMed Web of Science ®Google Scholar
• Petkova SB, Konstantinov KN, Sproule TJ, Lyons BL, Awwami MA, Roopenian DC. Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor Fc γ RIIB. J. Exp. Med.203(2), 275–280 (2006).
   PubMed Web of Science ®Google Scholar
• Wan EC, Gordon TP, Jackson MW. Autoantibody-mediated bladder dysfunction in type 1 diabetes. Scand. J. Immunol.65(1), 70–75 (2007).
   PubMed Web of Science ®Google Scholar
• Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann. Neurol.61(6), 544–551 (2007).
   PubMed Web of Science ®Google Scholar
• Katzav A, Solodeev I, Brodsky O et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum.56(3), 938–948 (2007).
   PubMed Web of Science ®Google Scholar
• Nishie W, Sawamura D, Goto M et al. Humanization of autoantigen. Nat. Med.13(3), 378–383 (2007).
   PubMed Web of Science ®Google Scholar
• Stromnes IM, Goverman JM. Passive induction of experimental allergic encephalomyelitis. Nat. Protoc.1(4), 1952–1960 (2006).
   PubMed Web of Science ®Google Scholar
• Stromnes IM, Goverman JM. Active induction of experimental allergic encephalomyelitis. Nat. Protoc.1(4), 1810–1819 (2006).
   PubMed Web of Science ®Google Scholar
• Huizinga R, Heijmans N, Schubert P et al. Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice. J. Neuropathol. Exp. Neurol.66(4), 295–304 (2007).
   PubMedGoogle Scholar
• Vincent A, Lily O, Palace J. Pathogenic autoantibodies to neuronal proteins in neurological disorders. J. Neuroimmunol.100(1–2), 169–180 (1999).
   PubMedGoogle Scholar
• D’Andrea MR. Add Alzheimer’s disease to the list of autoimmune diseases. Med. Hypotheses64(3), 458–463 (2005).
   PubMed Web of Science ®Google Scholar
• Arshavsky YI. Alzheimer’s disease, brain immune privilege and memory: a hypothesis. J. Neural. Transm.113(11), 1697–1707 (2006).
   PubMedGoogle Scholar
• Orr CF, Rowe DB, Mizuno Y, Mori H, Halliday GM. A possible role for humoral immunity in the pathogenesis of Parkinson’s disease. Brain128(Pt 11), 2665–2674 (2005).
   PubMed Web of Science ®Google Scholar
• Haass M, Lehmann H. New aspects of autoantibody detection with a new combination of autoantigenic targets. Clin. Appl. Immunol. Rev.1(3–4), 193–200 (2001).
   Google Scholar
• Kawasaki E, Eisenbarth GS. High-throughput radioassays for autoantibodies to recombinant autoantigens. Front Biosci.5, E181–E190 (2000).
   PubMed Web of Science ®Google Scholar
• Li QZ, Zhou J, Wandstrat AE et al. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin. Exp. Immunol.147(1), 60–70 (2007).
   PubMed Web of Science ®Google Scholar
• Graham KL, Vaysberg M, Kuo A, Utz PJ. Autoantigen arrays for multiplex analysis of antibody isotypes. Proteomics6(21), 5720–5724 (2006).
   PubMed Web of Science ®Google Scholar
• Nano R, Balegno S, Vaccarone R, Corato M, Ceroni M. Detection of paraneoplastic anti-neuronal-specific antibodies: comparison of different immunohistochemical techniques. Anticancer Res.23(3B), 2377–2381 (2003).
   PubMedGoogle Scholar
• Boscolo S, Passoni M, Baldas V et al. Detection of anti-brain serum antibodies using a semi-quantitative immunohistological method. J. Immunol. Methods309(1–2), 139–149 (2006).
   PubMedGoogle Scholar
• Dalakas MC, Li M, Fujii M, Jacobowitz DM. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology57(5), 780–784 (2001).
   PubMedGoogle Scholar
• Rakocevic G, Raju R, Dalakas MC. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch. Neurol.61(6), 902–904 (2004).
   PubMedGoogle Scholar
• Rakocevic G, Raju R, Semino-Mora C, Dalakas MC. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology67(6), 1068–1070 (2006).
   PubMed Web of Science ®Google Scholar
• Chang CC, Eggers SD, Johnson JK, Haman A, Miller BL, Geschwind MD. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt–Jakob disease. Clin. Neurol. Neurosurg.109(1), 54–57 (2007).
   PubMedGoogle Scholar
• Vianello M, Tavolato B, Armani M, Giometto B. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies. Cerebellum (London)2(1), 77–79 (2003).
   PubMedGoogle Scholar
• Silber E, Semra YK, Gregson NA, Sharief MK. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology58(9), 1372–1381 (2002).
   PubMed Web of Science ®Google Scholar
• Eikelenboom MJ, Petzold A, Lazeron RH et al. Multiple sclerosis: neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology60(2), 219–223 (2003).
   PubMed Web of Science ®Google Scholar
• Kaiser R. Intrathecal immune response in patients with neuroborreliosis: specificity of antibodies for neuronal proteins. J. Neurol.242(5), 319–325 (1995).
   PubMedGoogle Scholar
• Storstein A, Monstad SE, Honnorat J, Vedeler CA. Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum. J. Neuroimmunol.155(1–2), 150–154 (2004).
   PubMed Web of Science ®Google Scholar
• Stich O, Graus F, Rasiah C, Rauer S. Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration. J. Neuroimmunol.141(1–2), 165–169 (2003).
   PubMed Web of Science ®Google Scholar
• Pereira RM, Yoshinari NH, De Oliveira RM, Cossermelli W. Antiganglioside antibodies in patients with neuropsychiatric systemic lupus erythematosus. Lupus1(3), 175–179 (1992).
   PubMed Web of Science ®Google Scholar
• Megevand P, Chizzolini C, Chofflon M, Roux-Lombard P, Lalive PH, Picard F. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren’s syndrome with central nervous system involvement. Eur. Neurol.57(3), 166–171 (2007).
   PubMed Web of Science ®Google Scholar
• Schrodl D, Kahlenberg F, Peter-Zimmer K, Hermann W, Kuhn HJ, Mothes T. Intrathecal synthesis of autoantibodies against tissue transglutaminase. J. Autoimmun.22(4), 335–340 (2004).
   PubMedGoogle Scholar
• Carson JH, Barbarese E, Braun PE, McPherson TA. Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein. Proc. Natl Acad. Sci. USA75(4), 1976–1978 (1978).
   PubMedGoogle Scholar
• Annunziata P, Pluchino S, Martino T, Guazzi G. High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis. J. Neuroimmunol.77(1), 128–133 (1997).
   PubMed Web of Science ®Google Scholar
• Mantegazza R, Cristaldini P, Bernasconi P et al. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association. Int. Immunol.16(4), 559–565 (2004).
   PubMed Web of Science ®Google Scholar
• Baig S, Olsson T, Yu-Ping J, Hojeberg B, Cruz M, Link H. Multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid. Scand. J. Immunol.33(1), 73–79 (1991).
   PubMedGoogle Scholar
• Villar LM, Sadaba MC, Roldan E et al. Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. J. Clin. Invest.115(1), 187–194 (2005).
   PubMed Web of Science ®Google Scholar
• Reindl M, Khantane S, Ehling R et al. Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders. J. Neuroimmunol.145(1–2), 139–147 (2003).
   PubMedGoogle Scholar
• Ferracci F, Moretto G, Candeago RM et al. Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto’s encephalopathy. Neurology60(4), 712–714 (2003).
   PubMed Web of Science ®Google Scholar
• Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology59(5), 764–766 (2002).
   PubMed Web of Science ®Google Scholar
• Celet B, Akman-Demir G, Serdaroglu P et al. Anti-α B-crystallin immunoreactivity in inflammatory nervous system diseases. J. Neurol.247(12), 935–939 (2000).
   PubMed Web of Science ®Google Scholar
• Niehaus A, Shi J, Grzenkowski M et al. Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination. Ann. Neurol.48(3), 362–371 (2000).
   PubMedGoogle Scholar
• Williamson RA, Burgoon MP, Owens GP et al. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc. Natl Acad. Sci. USA98(4), 1793–1798 (2001).
   PubMedGoogle Scholar
• Bronstein JM, Lallone RL, Seitz RS, Ellison GW, Myers LW. A humoral response to oligodendrocyte-specific protein in MS: a potential molecular mimic. Neurology53(1), 154–161 (1999).
   PubMed Web of Science ®Google Scholar
• Mayo I, Arribas J, Villoslada P et al. The proteasome is a major autoantigen in multiple sclerosis. Brain125(Pt 12), 2658–2667 (2002).
   PubMed Web of Science ®Google Scholar
• Warren KG, Catz I. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid. J. Neurol. Sci.121(1), 66–73 (1994).
   PubMed Web of Science ®Google Scholar
• Banki K, Colombo E, Sia F et al. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J. Exp. Med.180(5), 1649–1663 (1994).
   PubMed Web of Science ®Google Scholar
• Vianello M, Morello F, Scaravilli T, Tavolato B, Giometto B. Tremor of the mouth floor and anti-glutamic acid decarboxylase autoantibodies. Eur. J. Neurol.10(5), 513–514 (2003).
   PubMed Web of Science ®Google Scholar
• Yoshimoto T, Doi M, Fukai N et al. Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid. Int. Med.44(11), 1174–1177 (2005).
   PubMedGoogle Scholar
• Ances BM, Dalmau JO, Tsai J, Hasbani MJ, Galetta SL. Downbeating nystagmus and muscle spasms in a patient with glutamic-acid decarboxylase antibodies. Am J. Ophthalmol.140(1), 142–144 (2005).
   PubMed Web of Science ®Google Scholar
• Stich O, Rauer S. Qualitative evidence of anti-Ri specific intrathecal antibody synthesis and quantification of anti-Ri antibodies in serial samples from a patient with anti-Ri syndrome. J. Neurol. Neurosurg. Psychiatry77(2), 282–283 (2006).
   PubMedGoogle Scholar
• Bataller L, Wade DF, Fuller GN, Rosenfeld MR, Dalmau J. Cerebellar degeneration and autoimmunity to zinc-finger proteins of the cerebellum. Neurology59(12), 1985–1987 (2002).
   PubMedGoogle Scholar
• Chinnery PF, Reading PJ, Milne D, Gardner-Medwin D, Turnbull DM. CSF antigliadin antibodies and the Ramsay Hunt syndrome. Neurology49(4), 1131–1133 (1997).
   PubMedGoogle Scholar
• Yoshio T, Onda K, Nara H, Minota S. Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum.54(2), 675–678 (2006).
   PubMed Web of Science ®Google Scholar
• DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med.7(11), 1189–1193 (2001).
   PubMed Web of Science ®Google Scholar
• Lai NS, Lan JL. Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations. Lupus9(5), 353–357 (2000).
   PubMed Web of Science ®Google Scholar
• Jedryka-Goral A, Zabek J, Wojciechowski B, Zaborski J, Chwalinska-Sadowska H, Czlonkowska A. Evaluation of cerebrospinal fluid for the presense of anticardiolipin antibodies (aCL) in NP-SLE patients. Clin. Rheumatol.19(4), 306–310 (2000).
   PubMedGoogle Scholar
• O’Connor KC, McLaughlin KA, De Jager PL et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat. Med.13(2), 211–217 (2007).
   PubMed Web of Science ®Google Scholar
• Overell JR, Willison HJ. Recent developments in Miller Fisher syndrome and related disorders. Curr. Opin. Neurol.18(5), 562–566 (2005).
   PubMedGoogle Scholar
• Bataller L, Dalmau J. Paraneoplastic neurologic syndromes. Neurol. Clin.21(1), 221–247, ix (2003).
   PubMed Web of Science ®Google Scholar
• Liguori R, Rizzi R, Vetrugno R et al. Steroid-responsive multifocal demyelinating neuropathy with central involvement. Muscle Nerve22(2), 262–265 (1999).
   PubMedGoogle Scholar
• Connolly AM, Pestronk A, Mehta S et al. Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of β-tubulin: clinical association with slowly progressive demyelinating polyneuropathy. Neurology48(1), 243–248 (1997).
   PubMed Web of Science ®Google Scholar
• Tagawa Y, Yuki N, Hirata K. The 301 to 314 amino acid residue of β-tubulin is not a target epitope for serum IgM antibodies in chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci.163(1), 44–46 (1999).
   PubMedGoogle Scholar
• Gono T, Matsuda M, Shimojima Y et al. Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody. J. Clin. Neurosci.13(6), 683–687 (2006).
   PubMed Web of Science ®Google Scholar
• Tagawa Y, Yuki N, Hirata K. Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy. Muscle Nerve23(6), 895–899 (2000).
   PubMed Web of Science ®Google Scholar
• Kwa MS, van Schaik IN, De Jonge RR et al. Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies. Brain126(Pt 2), 361–375 (2003).
   PubMedGoogle Scholar
• Nielsen JM, Korteweg T, Polman CH. Diagnosing MS: recent guidelines and future goals focusing on magnetic resonance imaging. Int. MS J.14(1), 29–34 (2007).
   PubMedGoogle Scholar
• Wong A. An update on opsoclonus. Curr. Opin. Neurol.20(1), 25–31 (2007).
   PubMed Web of Science ®Google Scholar
• Graus F, Delattre JY, Antoine JC et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J. Neurol. Neurosurg. Psychiatry75(8), 1135–1140 (2004).
   PubMed Web of Science ®Google Scholar
• Weizman DA, Leong WL. Anti-Ri antibody opsoclonus–myoclonus syndrome and breast cancer: a case report and a review of the literature. J. Surg. Oncol.87(3), 143–145 (2004).
   PubMedGoogle Scholar
• Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv. Ophthalmol.48(1), 12–38 (2003).
   PubMed Web of Science ®Google Scholar
• Freeman JM. Rasmussen’s syndrome: progressive autoimmune multi-focal encephalopathy. Pediatr. Neurol.32(5), 295–299 (2005).
   PubMedGoogle Scholar
• Meinck HM, Thompson PD. Stiff man syndrome and related conditions. Mov. Disord.17(5), 853–866 (2002).
   PubMed Web of Science ®Google Scholar
• Polizzi A, Huson SM, Vincent A. Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology62(5), 332–341 (2000).
   PubMedGoogle Scholar
• van Sorge NM, van der Pol WL, Jansen MD, van den Berg LH. Pathogenicity of anti-ganglioside antibodies in the Guillain–Barre syndrome. Autoimmun. Rev.3(2), 61–68 (2004).
   PubMed Web of Science ®Google Scholar
• Kuwabara S. Guillain–Barre syndrome. Curr. Neurol. Neurosci. Rep.7(1), 57–62 (2007).
   PubMed Web of Science ®Google Scholar
• Vincent A. Immunology of disorders of neuromuscular transmission. Acta Neurologica Scand.183, 1–7 (2006).
   Google Scholar
• Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat. Rev.2(10), 797–804 (2002).
   Google Scholar
• Maddison P. Neuromyotonia. Clin. Neurophysiol.117(10), 2118–2127 (2006).
   PubMed Web of Science ®Google Scholar
• Cohly HH, Panja A. Immunological findings in autism. Int. Rev. Neurobiol.71, 317–341 (2005).
   PubMed Web of Science ®Google Scholar
• Watts H, Kennedy PG, Thomas M. The significance of anti-neuronal antibodies in Alzheimer’s disease. J. Neuroimmunol.1(1), 107–116 (1981).
   PubMedGoogle Scholar
• Padmos RC, Bekris L, Knijff EM et al. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol. Psychiatry56(7), 476–482 (2004).
   PubMed Web of Science ®Google Scholar
• Majoie HJ, de Baets M, Renier W, Lang B, Vincent A. Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res.71(2–3), 135–141 (2006).
   PubMed Web of Science ®Google Scholar
• Verrotti A, Greco R, Altobelli E, Latini G, Morgese G, Chiarelli F. Anticardiolipin, glutamic acid decarboxylase, and antinuclear antibodies in epileptic patients. Clin. Exp. Med.3(1), 32–36 (2003).
   PubMedGoogle Scholar
• Mantegazza R, Bernasconi P, Baggi F et al. Antibodies against GluR3 peptides are not specific for Rasmussen’s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J. Neuroimmunol.131(1–2), 179–185 (2002).
   PubMedGoogle Scholar
• Hadjivassiliou M, Boscolo S, Davies-Jones GA et al. The humoral response in the pathogenesis of gluten ataxia. Neurology58(8), 1221–1226 (2002).
   PubMed Web of Science ®Google Scholar
• Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK. Serum autoantibodies to brain in Landau–Kleffner variant, autism, and other neurologic disorders. J. Pediatr.134(5), 607–613 (1999).
   PubMedGoogle Scholar
• Boscolo S, Baldas V, Gobbi G et al. Anti-brain but not celiac disease antibodies in Landau–Kleffner syndrome and related epilepsies. J. Neuroimmunol.160(1–2), 228–232 (2005).
   PubMed Web of Science ®Google Scholar
• Arnold PD, Richter MA. Is obsessive-compulsive disorder an autoimmune disease? CMAJ165(10), 1353–1358 (2001).
   PubMed Web of Science ®Google Scholar
• Jones AL, Mowry BJ, Pender MP, Greer JM. Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol. Cell Biol.83(1), 9–17 (2005).
   PubMed Web of Science ®Google Scholar
• Morer A, Lazaro L, Sabater L, Massana J, Castro J, Graus F. Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome. J. Psychiatr. Res.42(1), 64–68 (2008).
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Robertson D, Esler M, Straus SE, Eisenhofer G. Dysautonomias: clinical disorders of the autonomic nervous system. Ann. Intern. Med.137(9), 753–763 (2002).
   PubMedGoogle Scholar
• Vernino S, Ermilov LG, Sha L, Szurszewski JH, Low PA, Lennon VA. Passive transfer of autoimmune autonomic neuropathy to mice. J. Neurosci.24(32), 7037–7042 (2004).
   PubMed Web of Science ®Google Scholar
• Uthman I, Khamashta M. Ethnic and geographical variation in antiphospholipid (Hughes) syndrome. Ann. Rheum. Dis.64(12), 1671–1676 (2005).
   Google Scholar
• Muscal E, Brey RL. Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine. Int. J. Clin. Pract.61(9), 1561–1568 (2007).
   PubMed Web of Science ®Google Scholar
• Craig D, Robins G, Howdle PD. Advances in celiac disease. Curr. Opin. Gastroenterol.23(2), 142–148 (2007).
   PubMedGoogle Scholar
• Torok HP, Folwaczny C. Pancreatic autoantibodies in Crohn’s disease: a feasible diagnostic tool? Eur. J. Gastroenterol. Hepatol.17(1), 37–39 (2005).
   PubMedGoogle Scholar
• Gondim FA, Brannagan TH 3rd, Sander HW, Chin RL, Latov N. Peripheral neuropathy in patients with inflammatory bowel disease. Brain128(Pt 4), 867–879 (2005).
   PubMed Web of Science ®Google Scholar
• Todd JA. Genetic control of autoimmunity in Type 1 diabetes. Immunol. Today11(4), 122–129 (1990).
   PubMedGoogle Scholar
• Vianello M, Keir G, Giometto B, Betterle C, Tavolato B, Thompson EJ. Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies. Eur. J. Neurol.12(4), 294–299 (2005).
   PubMed Web of Science ®Google Scholar
• Uzenot D, Suchet L, Feuillet L, Rey M, Pelletier J, Ali Cherif A. [Hashimoto’s encephalitis and sleep disorders]. Revue Neurologique159(8–9), 793–794 (2003).
   PubMedGoogle Scholar
• Mahmud FH, Lteif AN, Renaud DL, Reed AM, Brands CK. Steroid-responsive encephalopathy associated with Hashimoto’s thyroiditis in an adolescent with chronic hallucinations and depression: case report and review. Pediatrics112(3 Pt 1), 686–690 (2003).
   PubMedGoogle Scholar
• Caturegli P, Kimura H, Rocchi R, Rose NR. Autoimmune thyroid diseases. Curr. Opin. Rheumatol.19(1), 44–48 (2007).
   PubMed Web of Science ®Google Scholar
• Nugent DJ. Immune thrombocytopenic purpura of childhood. Hematology/the Education Program of the American Society of Hematology. Am. Soc. Hematol.97–103 (2006).
   PubMedGoogle Scholar
• Kurata Y, Miyagawa S, Kosugi S et al. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura. Thromb. Haemost.71(2), 184–187 (1994).
   PubMed Web of Science ®Google Scholar
• Zimmerman SA, Ware RE. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura. J. Pediatr. Hematol. Oncol.19(4), 297–303 (1997).
   PubMedGoogle Scholar
• Nadeau SE. Neurologic manifestations of systemic vasculitis. Neurol. Clin.20(1), 123–150, vi (2002).
   PubMedGoogle Scholar
• Fujieda M, Oishi N, Kurashige T. Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment. Clin. Exp. Immunol.107(1), 120–126 (1997).
   PubMed Web of Science ®Google Scholar
• Gupta M, Johann-Liang R, Bussel JB, Gersony WM, Lehman TJ. Elevated IgA and IgM anticardiolipin antibodies in acute Kawasaki disease. Cardiology97(4), 180–182 (2002).
   PubMedGoogle Scholar
• Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica. Neurologist13(1), 2–11 (2007).
   PubMedGoogle Scholar
• Chan KH, Tsang KL, Fong GC, Cheung RT, Ho SL. Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica. Clin. Neurol. Neurosurg.107(2), 132–135 (2005).
   PubMed Web of Science ®Google Scholar
• Toh BH, Alderuccio F. Pernicious anaemia. Autoimmunity37(4), 357–361 (2004).
   PubMed Web of Science ®Google Scholar
• Nishimura K, Sugiyama D, Kogata Y et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann. Intern. Med.146(11), 797–808 (2007).
   PubMed Web of Science ®Google Scholar
• Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin. Arthritis Rheum.34(2), 501–537 (2004).
   Google Scholar
• Hirohata S, Arinuma Y, Takayama M, Yoshio T. Association of cerebrospinal fluid anti-ribosomal P protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res. Ther.9(3), R44 (2007).
   PubMed Web of Science ®Google Scholar
• Amarasena R, Bowman S. Sjogren’s syndrome. Clin. Med.7(1), 53–56 (2007).
   PubMedGoogle Scholar
• Finkielman JD, Lee AS, Hummel AM et al. ANCA are detectable in nearly all patients with active severe Wegener’s granulomatosis. Am. J. Med.120(7), 643e9–643e14 (2007).
   Google Scholar
• Nagashima T, Maguchi S, Terayama Y et al. P-ANCA-positive Wegener’s granulomatosis presenting with hypertrophic pachymeningitis and multiple cranial neuropathies: case report and review of literature. Neuropathology20(1), 23–30 (2000).
   PubMed Web of Science ®Google Scholar
• Anglin RE, Rosebush PI, Mazurek MF. The neuropsychiatric profile of Addison’s disease: revisiting a forgotten phenomenon. J. Neuropsychiatry Clin. Neurosci.18(4), 450–459 (2006).
   PubMed Web of Science ®Google Scholar
• Persoons P, Vermeire S, Demyttenaere K et al. The impact of major depressive disorder on the short- and long-term outcome of Crohn’s disease treatment with infliximab. Aliment. Pharmacol. Therapeut.22(2), 101–110 (2005).
   PubMed Web of Science ®Google Scholar
• Massengale J. Depression and the adolescent with Type 1 diabetes: the covert comorbidity. Issues Ment. Health Nurs.26(2), 137–148 (2005).
   PubMedGoogle Scholar
• Trzepacz PT, McCue M, Klein I, Levey GS, Greenhouse J. A psychiatric and neuropsychological study of patients with untreated Graves’ disease. Gen. Hosp. Psychiatry10(1), 49–55 (1988).
   PubMed Web of Science ®Google Scholar
• Vogel A, Elberling TV, Hording M et al. Affective symptoms and cognitive functions in the acute phase of Graves’ thyrotoxicosis. Psychoneuroendocrinology32(1), 36–43 (2007).
   PubMedGoogle Scholar
• Lazaridis KN, Talwalkar JA. Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. J. Clin. Gastroenterol.41(5), 494–500 (2007).
   PubMedGoogle Scholar
• van Os E, van den Broek WW, Mulder PG, Ter Borg PC, Bruijn JA, van Buuren HR. Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J. Hepatol.46(6), 1099–1103 (2007).
   PubMed Web of Science ®Google Scholar
• Conti F, Alessandri C, Bompane D et al. Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res. Ther.6(4), R366–R372 (2004).
   Web of Science ®Google Scholar
• Margutti P, Sorice M, Conti F et al. Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations. Arthritis Res. Ther.7(4), R896–R903 (2005).
   Google Scholar
• Yesudian PD, Edirisinghe DN, O’Mahony C. Behcet’s disease. Int. J. Sex. Trans. Dis. AIDS18(4), 221–227 (2007).
   PubMedGoogle Scholar
• Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behcet’s disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain122(Pt 11), 2171–2182 (1999).
   PubMed Web of Science ®Google Scholar
• Kierszenbaum F. Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol.21(11), 513–516 (2005).
   PubMed Web of Science ®Google Scholar
• Lury KM, Castillo M. Chagas’ disease involving the brain and spinal cord: MRI findings. Am. J. Roentgenol.185(2), 550–552 (2005).
   PubMed Web of Science ®Google Scholar
• Ghosh S, Seward R, Costello CE, Stollar BD, Huber BT. Autoantibodies from synovial lesions in chronic, antibiotic treatment-resistant Lyme arthritis bind cytokeratin-10. J. Immunol.177(4), 2486–2494 (2006).
   PubMedGoogle Scholar
• Stern BJ. Neurological complications of sarcoidosis. Curr. Opin. Neurol.17(3), 311–316 (2004).
   PubMed Web of Science ®Google Scholar
• Markovic M, Trajkovic V, Drulovic J et al. Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients. J. Neurol. Sci.211(1–2), 67–73 (2003).
   PubMedGoogle Scholar
• Damico FM, Kiss S, Young LH. Vogt–Koyanagi–Harada disease. Sem. Ophthalmol.20(3), 183–190 (2005).
   PubMedGoogle Scholar
• Hedstrand H, Perheentupa J, Ekwall O et al. Antibodies against hair follicles are associated with alopecia totalis in autoimmune polyendocrine syndrome type I. J. Invest. Dermatol.113(6), 1054–1058 (1999).
   PubMed Web of Science ®Google Scholar
• Ruiz-Doblado S, Carrizosa A, Garcia-Hernandez MJ. Alopecia areata: psychiatric comorbidity and adjustment to illness. Int. J. Dermatol.42(6), 434–437 (2003).
   PubMed Web of Science ®Google Scholar
• Margutti P, Delunardo F, Ortona E. Autoantibodies associated with psychiatric disorders. Current neurovascular research, 3(2), 149–157 (2006).
   Google Scholar
• von Mikecz A, Konstantinov K, Buchwald DS, Gerace L, Tan EM. High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum.40(2), 295–305 (1997).
   PubMed Web of Science ®Google Scholar